63 results
424B5
TPST
Tempest Therapeutics, Inc.
20 Jun 24
Prospectus supplement for primary offering
8:32am
reporting companies have reduced disclosure obligations regarding executive compensation. Additionally, as a smaller reporting company, we may continue
424B3
wu2dml1829f4wnir72
27 May 22
Prospectus supplement
9:01am
DEFA14A
gdl8rcg zo4fj
26 May 22
Additional proxy soliciting materials
4:06pm
DEFA14A
pv5dyfzxoauopv
9 May 22
Additional proxy soliciting materials
8:01am
PRE 14A
t1eq 59za
22 Apr 22
Preliminary proxy
4:01pm